4.8 Review

Administration, distribution, metabolism and elimination of polymer therapeutics

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 161, Issue 2, Pages 446-460

Publisher

ELSEVIER
DOI: 10.1016/j.jconrel.2011.12.021

Keywords

Polymer therapeutics; Angiogenesis; ADME; Biodistribution; Angiogenesis-dependent diseases; Cancer

Funding

  1. Chief Scientist Office of the Ministry of Health, Israel [5145-300000]
  2. Israel Science Foundation [1309/10]
  3. Alon Foundation
  4. Israel Cancer Association
  5. United States-Israel Binational Science Foundation (BSF) [2007347]
  6. German-Israel Foundation (GIF)
  7. Israel Cancer Research Fund (ICRF)
  8. Association for International Cancer Research (AICR)
  9. TAU Center for Nanoscience and Nanotechnology
  10. Swiss Bridge
  11. Worldwide Cancer Research [11-0132] Funding Source: researchfish

Ask authors/readers for more resources

Polymer conjugation is an efficient approach to improve the delivery of drugs and biological agents, both by protecting the body from the drug (by improving biodistribution and reducing toxicity) and by protecting the drug from the body (by preventing degradation and enhancing cellular uptake). This review discusses the journey that polymer therapeutics make through the body, following the ADME (absorption, distribution, metabolism, excretion) concept. The biological factors and delivery system parameters that influence each stage of the process will be described, with examples illustrating the different solutions to the challenges of drug delivery systems in vivo. (c) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available